6505--Lab supplies - Radiopharm - Amyvid

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 is seeking a contractor to provide Amyvid radiopharmaceutical injectable doses for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. This Request for Quote (RFQ) aims to establish a 5-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for delivering approximately 36 single-unit doses of Amyvid annually, which are used for PET imaging studies to evaluate Alzheimer's disease. The solicitation is an unrestricted procurement under NAICS code 325412 with a size standard of 1,300 employees. Interested vendors must submit quotes by March 6, 2025, at 3:00 PM EST, with any questions required to be submitted by March 4, 2025. The contractor must provide FDA-approved Amyvid doses calibrated to 10 mCi 10% activity, delivered to the Nuclear Medicine Hot Lab with proper dose administration systems.

The contract will have a performance period from March 14, 2025, through March 13, 2030, with a minimum contract value of $3,000 and a maximum of $1,000,000. Deliveries will be made Monday through Friday during standard hours, excluding federal holidays, and the government will issue 12-month unilateral task orders contingent upon funding availability. The place of performance is located in Philadelphia, PA 19104. No specific set-aside designations are applied to this solicitation, making it open to all qualified vendors. The Nuclear Medicine department will receive doses that must be precisely calibrated and administered through appropriate systems, ensuring high-quality diagnostic imaging capabilities for Alzheimer's disease research and patient care. Task orders will be issued annually, providing flexibility for the VA Medical Center to manage its radiopharmaceutical needs throughout the contract period.